AutoICD API

75548-8

Laboratory

Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA

Definition

This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.

LOINC 6-Axis Classification

Component

Fetal trisomy 13 risk

Property

Likelihood

Time Aspect

Pt

System

WBC.DNA+Plas.cfDNA

Scale Type

Qn

Method Type

Dosage of chromosome specific cf DNA

Details

Class

MOLPATH.TRISOMY

Order/Observation

Both

Short Name

Fet Ts 13 risk WBC.DNA+cfDNA Qn

Display Name

Trisomy 13 risk Dosage of chromosome-specific cfDNA Qn (Plasma cell-free+WBC DNA)

Related Names

ChromosomChromosomesGeneticsHeredityHeritableInheritedLeukocytesMolecular pathologyMOLPATHMOLPATH.TRISOMYPatau syndromePlPlasmaPlsmPoint in timeQNTQuanQuantQuantitativeRandomRiskSpecTsTs 13 riskWBC.DNA+cfDNAWBCsWhite blood cells

Frequently Asked Questions

What is LOINC code 75548-8?

LOINC code 75548-8 identifies "Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA". This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.

What does 75548-8 measure?

This code measures Fetal trisomy 13 risk in WBC.DNA+Plas.cfDNA. It belongs to the MOLPATH.TRISOMY class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.